Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder The Risks of Prescribing Hydroxychloroquine in COVID-19-Infected Patients With Schizophrenia PDF $40.00
$40.00
× Placeholder Eyelash Loss Secondary to Escitalopram But Not to Sertraline: A Case Report PDF $40.00
$40.00
× Placeholder The Prevalence and Severity of Depressive Symptoms Along the Spectrum of Unipolar Depressive Disorders: A Post Hoc Analysis PDF $40.00
$40.00
× Placeholder Elevated Levels of Insulin, Leptin, and Blood Lipids in Olanzapine-Treated Patients With Schizophrenia or Related Psychoses PDF $40.00
$40.00
× Placeholder Ethnicity and Treatment Response in Schizophrenia: A Comparison of 3 Ethnic Groups PDF $40.00
$40.00
× Placeholder Effectiveness of a Brief Behavioral Treatment for Inner-City Illicit Drug Users With Elevated Depressive Symptoms: The Life Enhancement Treatment for Substance Use (LETS Act!) PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $240.00
Total $240.00
Proceed to checkout

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe